ARM CEO Forum is a community for ARM member leaders to engage in discussion and to obtain counsel and resources from professional peers. ARM encourages members of this Forum to share challenges, best practices, questions, and perspective regarding all aspects of developing regenerative medicines and getting them to the patients who need them.
We hope this Forum will be a source of support and insight, and encourage you to take away as much learning as possible. However, we ask that you do not quote individuals who have posted here, without the author’s permission.
Participants in this Forum have been confirmed as an ARM member’s top executive. To ensure the best possible experience for all Forum members, we ask that you please review and adhere to the following rules and etiquette guidelines for our community.
Guidelines
Please note carefully all items listed in the disclaimer and legal rules below, particularly regarding the copyright ownership of information posted to the Community, as well as in ARM’s Privacy Statement and Antitrust Compliance Statement.
Legal Disclaimer
These social media pages, accounts, and sites are provided as a service of ARM. ARM is not responsible for the opinions and information posted on these sites by others. ARM disclaims all warranties with regard to information posted on these sites, whether posted by ARM or any third party; this disclaimer includes all implied warranties of merchantability and fitness. In no event shall ARM be liable for any special, indirect, or consequential damages or any damages whatsoever resulting from loss of use, data, or profits, arising out of or in connection with the use or performance of any information posted on this site.
Do not post any defamatory, abusive, profane, threatening, offensive, or illegal materials. Do not post any information or other material protected by copyright without the permission of the copyright owner. In addition, while ARM will not directly quote individuals without their express permission, high-level “key takeaways” from these discussions regarding the research, development, financing, reimbursement, and patient access environment for regenerative medicines may be used in ARM presentations, reports, and other print and electronic materials.
Content should not be posted if it encourages or facilitates members to arrive at any agreement that either expressly or impliedly leads to price fixing, a boycott of another’s business, or other conduct intended to illegally restrict free trade. Content that encourages or facilitates an agreement about the following subjects are inappropriate: prices, discounts, or terms or conditions of sale; salaries; profits, profit margins, or cost data; market shares, sales territories, or markets; allocation of customers or territories; or selection, rejection, or termination of customers or suppliers. ARM does not actively monitor these sites for inappropriate postings and does not on its own undertake editorial control of postings. However, in the event that any inappropriate posting is brought to ARM’s attention, ARM will take all appropriate action.
ARM reserves the right to block or remove any users who do not abide by these guidelines.
